Show simple item record

Impaired Retinal Vasoreactivity: An Early Marker of Stroke Risk in Diabetes

dc.contributor.authorBettermann, Kerstin
dc.contributor.authorSlocomb, Julia
dc.contributor.authorShivkumar, Vikram
dc.contributor.authorQuillen, David
dc.contributor.authorGardner, Thomas W.
dc.contributor.authorLott, Mary E.
dc.date.accessioned2017-02-02T22:02:07Z
dc.date.available2018-03-01T16:43:51Zen
dc.date.issued2017-01
dc.identifier.citationBettermann, Kerstin; Slocomb, Julia; Shivkumar, Vikram; Quillen, David; Gardner, Thomas W.; Lott, Mary E. (2017). "Impaired Retinal Vasoreactivity: An Early Marker of Stroke Risk in Diabetes." Journal of Neuroimaging 27(1): 78-84.
dc.identifier.issn1051-2284
dc.identifier.issn1552-6569
dc.identifier.urihttps://hdl.handle.net/2027.42/136050
dc.description.abstractDiabetes is a common cause of small vessel disease leading to stroke and vascular dementia. While the function and structure of large cerebral vessels can be easily studied, the brain’s microvasculature remains difficult to assess. Previous studies have demonstrated that structural changes in the retinal vessel architecture predict stroke risk, but these changes occur at late disease stages. Our goal was to examine whether retinal vascular status can predict cerebral small vessel dysfunction during early stages of diabetes. Retinal vasoreactivity and cerebral vascular function were measured in 78 subjects (19 healthy controls, 22 subjects with prediabetes, and 37 with type‐2 diabetes) using a new noninvasive retinal imaging device (Dynamic Vessel Analyzer) and transcranial Doppler studies, respectively. Cerebral blood vessel responsiveness worsened with disease progression of diabetes. Similarly, retinal vascular reactivity was significantly attenuated in subjects with prediabetes and diabetes compared to healthy controls. Subjects with prediabetes and diabetes with impaired cerebral vasoreactivity showed mainly attenuation of the retinal venous flicker response. This is the first study to explore the relationship between retinal and cerebral vascular function in diabetes. Impairment of venous retinal responsiveness may be one of the earliest markers of vascular dysfunction in diabetes possibly indicating subsequent risk of stroke and vascular dementia.
dc.publisherWiley Periodicals, Inc.
dc.publisherSpringer
dc.subject.otherRetinal vasoreactivity
dc.subject.otherTCD
dc.subject.otheroptic imaging
dc.titleImpaired Retinal Vasoreactivity: An Early Marker of Stroke Risk in Diabetes
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelNeurosciences
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/136050/1/jon12412.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/136050/2/jon12412_am.pdf
dc.identifier.doi10.1111/jon.12412
dc.identifier.sourceJournal of Neuroimaging
dc.identifier.citedreferenceKornerup T. Retinopathia diabetica proliferans. Acta Ophthalmol 1958; 36: 87 ‐ 101.
dc.identifier.citedreferenceLott ME, Slocomb JE, Gabbay RA, et al. Impaired coronary and retinal vasomotor function to hyperoxia in Individuals with type 2 diabetes. Microvasc Res 2015; 101: 1 ‐ 7.
dc.identifier.citedreferenceWidder B. Doppler‐ and duplexsonographie der hirnversorgenden Arterien. 5th ed. Heidelberg, Germany: Springer, 1999: 347 ‐ 70.
dc.identifier.citedreferenceSettakis G, Páll D, Molnár C, et al. Hyperventilation‐induced cerebrovascular reactivity among hypertensive and healthy adolescents. Kidney Blood Press Res 2006; 29: 306 ‐ 11.
dc.identifier.citedreferenceSugimori H, Ibayashi S, Fujii K, et al. Can transcranial Doppler really detect reduced cerebral perfusion states ? Stroke 1995; 26: 2053 ‐ 60.
dc.identifier.citedreferenceBentsen N, Larsen B, Lassen NA. Chronically impaired autoregulation of cerebral blood flow in long‐term diabetics. Stroke 1975; 6: 497 ‐ 502.
dc.identifier.citedreferenceCheah YS, Amiel SA. Metabolic neuroimaging of the brain in diabetes mellitus and hypoglycaemia. Nat Rev Endocrinol 2012; 8: 588 ‐ 97.
dc.identifier.citedreferenceHou Q, Zuo Z, Michel P, et al. Influence of chronic hyperglycemia on cerebral microvascular remodeling: an in vivo study using perfusion computed tomography in acute ischemic stroke patients. Stroke 2013; 44: 3557 ‐ 60.
dc.identifier.citedreferencede la Torre JC. Cerebral hemodynamics and vascular risk factors: setting the stage forAlzheimer’s disease. J Alzheimers Dis 2012; 32: 553 ‐ 67.
dc.identifier.citedreferenceLott ME, Slocomb JE, Shivkumar V, et al. Comparison of retinal vasodilator and constrictor responses in type2 diabetes. Acta Ophthalmol 2012; 90: e434 ‐ 41.
dc.identifier.citedreferenceBallantyne AJ. Retinal changes associated with diabetes and with hypertension. Arch Ophthal 1945; 33: 97 ‐ 105.
dc.identifier.citedreferenceHardin AC, Jackson RL, Johnston TL, et al. The development of diabetic retinopathy. Diabetes 1956; 5: 397 ‐ 405.
dc.identifier.citedreferenceJuette A. Ueber die Erweiterung der Netzhautvenen bei jugendlischen Diabetikern. Diabetische Angiopathie. Berlin: Akademie‐Verlag, 1964: 13 ‐ 9.
dc.identifier.citedreferenceDitzel J. Functional microangiopathy in diabetes mellitus. Diabetes 1968; 6: 388 ‐ 97.
dc.identifier.citedreferenceMylius: Diabetische Augenkrankungen und ihre Behandlung. Klin Monatsbl Augenh 1937; 98: 377 ‐ 8.
dc.identifier.citedreferenceWong, TY, Klein R, Sharrett AR, et al. Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA 2002; 287: 1153 ‐ 9.
dc.identifier.citedreferenceBettermann K, Slocomb JE, Shivkumar V, et al. Retinal vasoreactivity as a marker for chronic ischemic white matter disease ? J Neurol Sci 2012; 322: 206 ‐ 10.
dc.identifier.citedreferenceOrasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 2009; 53: S35 ‐ 42.
dc.identifier.citedreferenceAiello LP, Sun W, Das A, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643 ‐ 53.
dc.identifier.citedreferenceHolman RR, Paul SK, Bethel MA, et al. 10‐Year follow‐up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577 ‐ 89.
dc.identifier.citedreferencePatel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560 ‐ 72.
dc.identifier.citedreferenceGerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545 ‐ 59.
dc.identifier.citedreferenceJax TW. Metabolic memory: a vascular perspective. Cardiovasc Diabetol 2010; 9: 51.
dc.identifier.citedreferenceCreager MA, Lüscher TF, Cosentino F, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation 2003; 108: 1527 ‐ 32.
dc.identifier.citedreferenceMandecka A, Dawczynski J, Blum M, et al. Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care 2007; 30: 3048 ‐ 52.
dc.identifier.citedreferenceLott ME, Slocomb JE, Shivkumar V, et al. Impaired retinal vasodilator responses in prediabetes and type 2 diabetes. Acta Ophthalmol 2013; 91: e462 ‐ 9.
dc.identifier.citedreferenceSchmetterer L, Wolzt M. Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia 1999; 42: 387 ‐ 405.
dc.identifier.citedreferencePournaras CJ, Rungger‐Brandle E, Riva CE, et al. Regulation of retinal blood flow in health and disease. Prog Retin Eye Res 2008; 27: 284 ‐ 330.
dc.identifier.citedreferenceWong TY, Kamineni A, Klein R, et al. Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: the cardiovascular health study. Arch Intern Med 2006; 166: 2388 ‐ 94.
dc.identifier.citedreferenceWang JJ, Liew G, Klein R, et al. Retinal vessel diameter and cardiovascular mortality: pooled data analysis from two older populations. Eur Heart J 2007; 28: 1984 ‐ 92.
dc.identifier.citedreferenceMcGeechan K, Liew G, Macaskill P, et al. Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual‐participant meta‐analysis. Am J Epidemiol 2009; 170: 1323 ‐ 32.
dc.identifier.citedreferenceIkram MK, de Jong FJ, Vingerling JR, et al. Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. Invest Ophthalmol Vis Sci 2004; 45: 2129 ‐ 34.
dc.identifier.citedreferenceWong TY, Klein R, Couper DJ, et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 2001; 358: 1134 ‐ 40.
dc.identifier.citedreferenceKawasaki R, Xie J, Cheung N, et al. MESA. Retinal microvascular signs and risk of stroke: the Multi‐Ethnic Study of Atherosclerosis (MESA). Stroke 2012; 43: 3245 ‐ 51.
dc.identifier.citedreferenceNagel E, Vilser W. Flicker observation light induces diameter response in retinal arterioles: a clinical methodological study. Br J Ophthalmol 2004; 88: 54 ‐ 6.
dc.identifier.citedreferenceFormaz F, Riva CE, Geiser M. Diffuse luminance flicker increases retinal vessel diameter in humans. Curr Eye Res 1997; 16: 1252 ‐ 7.
dc.identifier.citedreferenceMichelson G, Patzelt A, Harazny J. Flickering light increases retinal blood flow. Retina 2001; 22: 336 ‐ 43.
dc.identifier.citedreferenceWidder B. Use of breath holding for evaluating cerebrovascular reserve capacity. Stroke 1992; 23: 1680 ‐ 1.
dc.identifier.citedreferenceKim YS, Immink RV, Stok WJ, et al. Dynamic cerebral autoregulation capacity is affected early in type 2 diabetes. Clin Sci 2008; 5: 255 ‐ 62.
dc.identifier.citedreferenceGarhofer G, Zawinka C, Resch H, et al. Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes. Br J Ophthalmol 2004; 88: 887 ‐ 91.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.